Buy Microderil solution 1% 20ml

Microderil solution 1% 20ml

Condition: New product

998 Items


More info

Active ingredients


Release form



The composition of 1 ml: Active ingredient: naftifine hydrochloride - 10.0 mg. Auxiliary substances: propylene glycol - 50.0 mg, ethanol (ethyl alcohol 95%) - 400.0 mg, purified water - up to 1 ml.

Pharmacological effect

Mikoderil, solution for external use, 1% - antifungal agent intended for external use, belonging to the class of allylamino. Its active ingredient is naftifine. The mechanism of action is associated with inhibition of squalene-2,3-epoxidase, which leads to a decrease in the formation of ergosterol, which is part of the cell wall of the fungus. Naftifine, affecting squalene epoxidase, does not affect the cytochrome P-450 system. Nafttifin is active against dermatophytes, such as Trichophyton, Epidermophyton, Microsporum, yeast and yeast-like fungi (Candida spp., Pityrosporum), mold fungi, asparagus, asparagus and aspirantus, asparagus, asparagus and asparagus, asparagus, asparagus, asparagus and asparagus, asparagus, asparagus, asparagus, asparagus, asparagus, asparagus, asparagus, asparagus, asparagus, asparagus, asparagus, asparagus. Sporothrix schenckii). With respect to dermatophytes and aspergillus, naftifine is fungicidal. In relation to yeast fungi, the drug exhibits fungicidal or fungistatic activity depending on the strain of the microorganism. Naftifine has antibacterial activity against gram-positive and gram-negative microorganisms that cause secondary bacterial infections. Nafttifin has an anti-inflammatory effect, which contributes to the rapid disappearance of the symptoms of inflammation, especially itching.


When applied externally, naftifine rapidly penetrates the skin, creating stable antifungal concentrations in its various layers, which makes it possible to use it once a day.


- fungal infections of smooth skin and skin folds (tinea corporis, tinea inquinalis); - interdigital mycoses (tinea manum, tinea pedum); - fungal infections of the nails (onychomycosis); - candidiasis of the skin; - pityriasis versicolor; - inflammatory ringworm (with itching or without him).


Hypersensitivity to naftifine or propylene glycol; pregnancy and lactation (the safety and efficacy of the drug in this category of patients has not been studied). The application of the drug on the wound surface is contraindicated.

Precautionary measures

With careKid's age (experience of clinical use is limited).

Use during pregnancy and lactation

The use of the drug during pregnancy and lactation is not recommended (the safety and efficacy of the drug in this category of patients has not been studied).

Dosage and administration

On dermatomycosis and candidiasis of the skin.Mikoderil, a solution for external use, 1% is applied once a day on the affected surface of the skin and adjacent areas after thorough cleaning and drying, capturing approximately 1 cm of healthy skin at the edges of the affected area.Duration treatment: for dermatomycosis - 2–4 weeks (up to 8 weeks if necessary), for candidiasis - 4 weeks. For nail lesions (onychomycosis). Before the first use of the drug, the affected part of the nail is removed as much as possible with a scissors and nail file. The drug is used 2 times a day, the duration of treatment for onychomycosis - up to 6 months. To prevent recurrence of infection, you should continue to use the drug for at least 2 weeks after the disappearance of clinical symptoms.

Side effects

In some cases, there may be local reactions: dry skin, skin flushing and burning. Side effects are reversible and do not require cancellation. If any of the side effects indicated in the instructions are aggravated, or any other side effects are noted that are not indicated in the instructions, you should immediately inform your doctor.


No cases of overdose have been reported.

Interaction with other drugs

Interaction with other drugs has not been studied.

special instructions

Mikoderil, a topical solution, is 1% effective in treating mycoses affecting areas of the skin with hyperkeratosis, as well as in hair growth areas. Course treatment is required. Avoid contact with eyes and open wounds. Use in pediatrics. With caution should use the drug in children.